Raed Attia

Venture Partner

Mikel Badiola

Venture Partner

Jingjing Chai

General Partner

Gray Chen

Co-Founding Partner and Venture Partner

Hongkai He

Founding Partner

Ricki Huang

Venture Partner

Diana Liu MD

Venture Partner

Huiliang Wang Ph.D

Venture Partner

Xudong Lv Ph.D

Venture Partner

36 past transactions

Kebotix

Venture Round in 2023
Kebotix is a high-tech materials discovery and production company. It is to reinvent the materials industry and enable a new age of discovery of new materials using AI, machine learning, and robotics. It was founded in 2017 and is headquartered in Cambridge, Massachusetts.

Finwave Semiconductor

Venture Round in 2022
Finwave Semiconductor develops a 3DGaN technology designed to enhance 5G devices.

Modern Synthesis

Seed Round in 2022
Modern Synthesis is bringing life to new materials by working with bacteria to commercially develop a new class of biobased textiles which offer: (1) Performance without plastics or harsh chemicals: Materials which achieve strength and durability without petrochemical binders, harmful chemistries or toxic byproducts. (2) Aesthetics without animals: A versatile process that unlocks a wide range of looks, feels, and functions to meet designers’ seasonal needs with zero animal inputs. (3) Scale without starting from scratch: A process that leverages abundant raw materials and is designed to integrate with existing manufacturing infrastructure. Modern Synthesis’ technology leverages the intrinsic versatility of bacterial nanocellulose, which is nature’s finest and strongest form of cellulose. Their process not only displaces animal leathers, plastic-based synthetics and other nonwoven textiles, but also generate entirely new possibilities for designers.

Aspecta

Seed Round in 2022
Aspecta transforms Web2 & Web3 footprints into AI-generated identity for builders and beyond. We revolutionize data potential with an interactive digital identity ecosystem.

WeBox

Series A in 2022
WeBox (Saltalk Inc) is an intelligent marketplace and providing the all-in-one shopping and delivery service for the workplace with individual meals, group catering and office pantry.

Cache

Pre Seed Round in 2022
Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to delete or dispose of anything ever again.

SanaHeal

Seed Round in 2022
SanaHeal provider of a bioadhesive tape designed to bind to tissues or organs

Regenerative Bio

Angel Round in 2022
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing, Regenerative Bio combines AI pharmaceutical-related technologies with biology to explore ingredients, formulations and therapies with anti-aging effects, and solve the problems caused by aging.

Revela Health

Seed Round in 2022
Revela is a direct-to-consumer company that discovers novel molecules for consumer health applications and creates better products using these new ingredients.

Kula Bio

Series A in 2022
Kula Bio specializes in sustainable, biological solutions for modern agriculture. It energizes nitrogen-fixing microbes to produce organic fertilizer. By rewiring the energy flow from the sun to soil, they are disrupting synthetic fertilizer to eliminate the division between affordable practices and stewardship of our land, sea, and air. The company was founded in 2018 and is headquartered in Somerville, Massachusetts.

Pantheon Design

Pre Seed Round in 2022
At Pantheon Design our mission is to build flexible manufacturing systems that hardware innovators and integrators to remove the pain of medium-scale manufacturing by providing an integrated 3D printing system able to deliver end-use quality parts at 10X the speed and 1/10 the cost.

WeTravel

Seed Round in 2021
WeTravel is an online payment platform that offers organizers with pre-departure tools to collect funds and organize logistics. Travel companies create elegant booking pages in minutes to collect deposits, set automatic payment plans, and manage financials securely from all over the world. Its platform has been used for a wide variety of trips, such as yoga retreats, student trips, bachelorette trips, dance trips, company retreats or sports team travel. Its website allows organizers to create a beautiful website for their trip in minutes. Organizers can collect deposits directly on the Wetravel platform and then easily transfer the funds to their account or directly to a travel agent or airline (even internationally, at much better exchange rates than banks.

Snaplii

Series A in 2021
Snaplii is a digital wallet that is committed to driving big changes in the North American Fintech industry. Snaplii provides a one-stop digital payment service along with unique membership and marketing program to better help our business partners increase traffic, boost sales and better engage with their consumers.

EasyTransfer

Series C in 2021
EasyTransfer is the leading online tuition payment services platform for international students, trusted by 280,000+ students and families, processing over US$3 Billion in transactions every year. We partner with Tencent, UnionPay and Cashfree Payments, and is the exclusive international education payment service on WeChat. With the most professional services, proprietary intelligent AML systems and compliance verification automations, EasyTransfer is integrated within most mobile banking apps and major online financial platforms. Our global payment network and innovative financial technologies make cross-border payments feel like domestic payments, which can arrive as fast as in the hour. In addition to a team of over 100 payment professionals with native fluency in the student family's home language, EasyTransfer offers a transparent, real-time bank market exchange rate with no markup. EasyTransfer offers a streamlined, user-friendly online interface in the native language for international students studying abroad. Our platform enables users to complete all their education payments, compliance paperwork, and progress tracking online.

Signet Therapeutics

Seed Round in 2021
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

Citcon

Series C in 2021
Founded in 2015, CITCON is a leading payment technology company, building a payment infrastructure that enables global merchants to accept payments from billions of fast-growing mobile wallet consumers through the web, mobile and in-store channels around the world. Mobile payment provides a more user-friendly, secure, and safer contactless shopping and payment experience for both consumers and merchants compared to other payment options. CITCON’s secure, scalable and open system allows businesses to quickly and easily accept domestic and international mobile wallets by using a single API suite and an integrated processing and fund settlement platform. Millions of mobile wallet consumers are now able to shop and pay at tens of thousands of merchants, online, mobile, and in-store. Citcon is headquartered in Silicon Valley, California, CITCON has five regional offices in the U.S., Canada, Europe, and Asia.

ZSFab

Seed Round in 2021
ZSFab dedicates to provide modeling optimization and 3D printing of patient specific surgical guide & biocompatible, biomechanical fit implants, surgical guides and anatomical models.

XtalPi

Series D in 2021
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide. Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies.

Nirvana

Seed Round in 2021
Nirvana is an AI-native financial infrastructure shaping the future of Agentic DeFi. - Redefining DeFi with AI Agents – Nirvana builds AI frameworks for DEFAI agents to maximize capital efficiency - AI-Native On-Chain Protocols – Empowering DEFAI agents with AI-native protocols to autonomously launch innovative financial instruments and optimize strategies

Relativity Space

Series E in 2021
Relativity Space is an aerospace company that designs, develops, and builds 3D-printed rockets. a vertically integrated technology platform, Relativity is at the forefront of an inevitable shift toward software-defined manufacturing by fusing 3D printing, artificial intelligence, and autonomous robotics. It offers a radically simplified supply chain, building a rocket with 100x fewer parts in less than 60 days. Relativity Space is backed by leading investors including Bond, Tribe Capital, Playground Global, Y Combinator, Social Capital, and Mark Cuban.

Bioz

Series A in 2021
Bioz delivers the world’s first search engine for life science experimentation. The Bioz platform empowers life scientists in academia and biopharma to quickly find, compare and select the right products for their experiments, ultimately speeding drug discovery and increasing the rate of success in finding cures for diseases.

ProteoWise

Venture Round in 2021
ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics. ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at Yale University with a history of innovation.

Databento

Convertible Note in 2021
Databento makes it simpler and faster to access financial market data. Founded by traders and engineers from world-class quantitative hedge funds, Databento's self-service model allows users to instantly pick up live exchange feeds and terabytes of historical data. Users have the flexibility to only pay for what they use, or opt for flat-rate pricing. Databento's servers are hosted in the colocation facilities of various trading venues for low-latency and high-fidelity data capture, directly from the source.

Cardea Bio

Series A in 2021
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog.

SnapPay

Seed Round in 2021
SnapPay is the leading North American payment platform enabling Alipay, WeChat Pay, and China UnionPay acceptance for North American merchants, permitting safe and secure online, in-store, in-app and mobile transactions. The marketing solutions of SnapPay also help merchants to expand their reach to new customers and generate more in-store and online revenue.

AltrixBio

Seed Round in 2021
AltrixBio is a developer of therapeutic drugs designed for controlled gastrointestinal targeting. They treat patients by providing duodenal isolation similar to gastric bypass, enabling patients with an oral drug that replicates the metabolic success of bariatric surgery and is quite financially feasible than surgery.

Concerto Biosciences

Seed Round in 2020
Concerto Biosciences rebuilds microbial communities in, on, and around us to heal our bodies and our planet. Products that rebuild microbial communities do not yet exist because no one can map the vast inter-species interaction networks responsible for community behavior. Concerto’s cofounders therefore invented the first-ever ultra-high-throughput platform to experimentally measure millions of microbial interactions. Concerto maps interaction networks that reveal a new class of products called “ensembles”—combinations of microbes that work in concert to shepherd damaged microbial communities to health. The opportunities are enormous: Concerto will become the premier inventor of ensembles across medicine and agriculture, reinventing humanity’s relationship with microbes.

Manus Bio

Series B in 2020
Manus Bio develops an advanced fermentation technology to recreate plant processes in microorganisms. Its technology helps in manufacturing complex and bioactive natural products such as flavors, fragrances, food ingredients, bio-pesticides, and pharmaceuticals.

Pointcloud

Seed Round in 2020
Pointcloud is a developer of a 3D imaging platform on a chip. The company offers a technology for big data analytics on 3D point clouds based on machine learning. It enables the future of augmented reality, robotics, and autonomous mobility.

Cardea Bio

Series A in 2020
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors. Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type, and quality of biological data they capture by building products that Conduct Biolog.

Butlr

Seed Round in 2020
Butlr is an AI people-sensing platform using body heat to detect occupancy, headcount, body posture, and activity, and generate accurate, real-time, and historical spatial insights for healthcare and sustainable buildings. Their sensor technology detects human presence anonymously using low-resolution thermal data and advanced AI and machine learning.

Galixir

Seed Round in 2020
Galixir is an artificial intelligence technology to promote the research and development of new drugs. Our artificial intelligence drug discovery platform can help drug research and development scientists greatly save time and cost in drug development. At the same time, our platform also provides comprehensive patent protection coverage for the drugs developed. Relying on cutting-edge artificial intelligence technology, Xingyao combines engineering chemistry, computational chemistry, computational biology, and cloud computing technologies to serve the various processes of drug development.

Kula Bio

Seed Round in 2020
Kula Bio specializes in sustainable, biological solutions for modern agriculture. It energizes nitrogen-fixing microbes to produce organic fertilizer. By rewiring the energy flow from the sun to soil, they are disrupting synthetic fertilizer to eliminate the division between affordable practices and stewardship of our land, sea, and air. The company was founded in 2018 and is headquartered in Somerville, Massachusetts.

LASE Innovation

Series A in 2020
LASE Innovation is an early stage startup that provides optics solutions for broad applications. The company is currently targeting life science and diagnostic markets by commercializing lase particles.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.